Full text
PDFPage 836

Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bestagno M., Pizzocaro C., Pagliaini R., Rossini P. L., Guerra P. Results of [131I]metaiodobenzylguanidine treatment in metastatic carcinoid. J Nucl Biol Med. 1991 Oct-Dec;35(4):343–345. [PubMed] [Google Scholar]
- Janmohamed S., Bloom S. R. Carcinoid tumours. Postgrad Med J. 1997 Apr;73(858):207–214. doi: 10.1136/pgmj.73.858.207. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Taal B. G., Hoefnagel C. A., Valdes Olmos R. A., Boot H., Beijnen J. H. Palliative effect of metaiodobenzylguanidine in metastatic carcinoid tumors. J Clin Oncol. 1996 Jun;14(6):1829–1838. doi: 10.1200/JCO.1996.14.6.1829. [DOI] [PubMed] [Google Scholar]
- Watanabe N., Seto H., Ishiki M., Shimizu M., Kageyama M., Wu Y. W., Nagayoshi T., Kamisaki Y., Kakishita M. I-123 MIBG imaging of metastatic carcinoid tumor from the rectum. Clin Nucl Med. 1995 Apr;20(4):357–360. doi: 10.1097/00003072-199504000-00014. [DOI] [PubMed] [Google Scholar]
- Zilembo N., Buzzoni R., Bajetta E., Di Bartolomeo M., de Braud F., Castellani R., Maffioli L., Celio L., Villa E., Lorusso V. Salvage treatment after r-interferon alpha-2a in advanced neuroendocrine tumors. Acta Oncol. 1993;32(2):245–250. doi: 10.3109/02841869309083920. [DOI] [PubMed] [Google Scholar]
